🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "targeted measures to tackle household expense challenges" in next month's financial statement.

Speaking to media outlets, she stated that lowering price rises is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is expected to be the highest among the G7 industrialized countries this calendar year and next.

Possible Utility Bill Measures

Reports indicate the government could intervene to bring down energy bills, for instance by cutting the present 5% level of value-added tax charged on energy.

A further approach is to cut some of the regulatory levies presently added to household expenses.

Budgetary Limitations and Expert Predictions

The administration will obtain the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these measures.

The expectation from the majority of analysts is that the Chancellor will have to announce tax increases or budget cuts in order to fulfill her voluntary debt limits.

Earlier on the same day, estimates showed there was a £22 billion gap for the chancellor to address, which is at the lower end of projections.

"It is a shared job between the Bank of England and the government to bear down further on some of the sources of price increases," Reeves told the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest information from the OBR had not altered her pledge to election pledges not to raise rates on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with growing geopolitical and trade tensions for the fiscal tax moves, likely to be targeted on those "most able to pay."

International Economic Disputes

Commenting on concerns about the UK's commercial links with the Asian nation she said: "Our security interests invariably are paramount."

Recent statement by Chinese authorities to tighten export controls on rare earths and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an extra 100% import tax on imports from China, increasing the possibility of an all-out trade war between the two economic giants.

The American finance chief called the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the action was "damaging for the world economy and creates additional challenges."

"In my view there are sectors where we must challenge China, but there are also valuable chances to export to China's economy, including banking sector and other sectors of the economy. We've got to achieve that equilibrium correct."

The chancellor also stated she was working with G7 counterparts "on our own critical minerals plan, so that we are reduced dependence."

NHS Drug Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on medicines could rise as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global drug companies have said in recent statements that they are either halting or scrapping projects in the United Kingdom, with several blaming the insufficient payments they are receiving.

Recently, the government science advisor said the price the health service spends on drugs would need to rise to stop firms and pharmaceutical investment departing from the United Kingdom.

The Chancellor told media: "It has been observed due to the cost structure, that medical research, new drugs have not been available in the UK in the extent that they are in other European countries."

"We want to ensure that patients getting care from the NHS are can obtain the top life-saving drugs in the world. And so we are looking at this situation, and... aiming to obtain more investment into Britain."